News
The Phase 2 VENTURE-Oral Dosing Trial is a randomized, double-blind, placebo-controlled multicenter study designed to evaluate the safety, tolerability, pharmacokinetics and weight loss efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback